Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ipilimumab
Psoriasis
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Psoriatic Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Mixed Phenotype Acute Leukemia
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Rheumatoid Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Sjogren Syndrome
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Systemic Lupus Erythematosus
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Systemic Sclerosis
National Cancer Institute (NCI)
P1
CC
(43)
Ipilimumab
Ulcerative Colitis
National Cancer Institute (NCI)
P1
CC
(43)
Kras Tcr-Transduced Pbl
Malignant Urinary System Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Lenalidomide
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)
P1
CC
(43)
Lenalidomide
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Metarrestin
Malignant Peripheral Nerve Sheath Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Methotrexate
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
mk-2206
Cutaneous Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Medullary Thyroid Gland Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Autoimmune Disease
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Crohn Disease
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Dermatomyositis
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Inflammatory Bowel Disease
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Invasive Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Psoriasis
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Psoriatic Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2876 to 2900 of 3,272 assets
Previous
Page 116 of 131
Next
